Fidelity Investments’s Histogen Inc. Common Stock HSTO Stock Holding History

Fidelity Investments’s Portfolio HSTO Stock Details HSTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5	Closed	–	–	5732
2022 Q1	$0	Buy	+5	New	+$25	﹤0.01%	5704
2021 Q2	–	Sell	-25	Closed	-$1K	–	5139
2021 Q1	$1K	Buy	+25	New	+$628	﹤0.01%	3920
2015 Q2	–	Sell	-945	Closed	-$1.35M	–	2834
2015 Q1	$1.35M	Buy	+945	New	+$1.2M	﹤0.01%	2483

Other funds holding HSTO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Fidelity Investments's HSTO Position: Q2 2022 in Review

Fidelity Investments sold out of Histogen Inc. Common Stock (HSTO) in Q2 2022, closing a stake of 5 shares.

Fidelity Investments first reported a position in HSTO in Q1 2015 and held it in 3 quarters. The position peaked at $1.35M in Q1 2015. 10 funds tracked by Wall St. Rank hold HSTO as of Q2 2022.

Fidelity Investments reported no remaining Histogen Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Fidelity Investments sold 5 Histogen Inc. Common Stock shares in Q2 2022.
Fidelity Investments first reported a position in Histogen Inc. Common Stock in Q1 2015 and held it in 3 quarters.
Fidelity Investments's Histogen Inc. Common Stock position peaked at $1.35M in Q1 2015.
10 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2022.

Based on Fidelity Investments's 13F filing for Q2 2022, filed 12 Aug 2022.